162 results on '"Kawase, Tatsuya"'
Search Results
2. Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation
3. IER5 Is a p53-Regulated Activator of HSF1 That Contributes to Promotion of Cancer
4. Potentiality of multiple modalities for single-cell analyses to evaluate the tumor microenvironment in clinical specimens
5. Supplementary Figures from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
6. Supplementary Data 4 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
7. Supplementary Data 6 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
8. Supplementary Data 2 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
9. Supplementary Data 5 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
10. Supplementary Data 3 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
11. Supplementary Data 1 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
12. Supplementary Table 1 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
13. Supplementary Table 2 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
14. Data from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
15. Identification of a novel oncogenic mutation of FGFR4 in gastric cancer
16. Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
17. Abstract LB361: Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death
18. Supplementary Figure S1. from ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma
19. Data from ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma
20. Supplementary Data from ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma
21. Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like tyrosine kinase 3 with venetoclax plus azacitidine in an acute myeloid leukemia xenograft mouse model
22. PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors
23. Hyperactive NK cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia
24. Cancer Susceptibility Polymorphism of p53 at Codon 72 Affects Phosphorylation and Degradation of p53 Protein
25. PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt
26. Metal-assisted chemical etching of Ge(100) surfaces in water toward nanoscale patterning
27. A flexible transcutaneous oxygen sensor using polymer membranes
28. Gilteritinib Enhances Graft-Versus-Leukemia Effects Against FLT3-ITD+ Leukemia after Mouse Allogeneic HSCT
29. Abstract 4561: Oncolytic vaccinia virus encoding IL-7 and IL-12 systemically sensitizes tumors to anti-PD-1 antibody in a syngeneic mouse model
30. Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis
31. Wearable and flexible oxygen sensor for transcutaneous oxygen monitoring
32. Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
33. Identification and characterization of the binding sequences and target genes of p53 lacking the 1st transactivation domain
34. Formation of Pyramidal Etch Pits Induced by Metallic Particles on Ge(100) Surfaces in Water
35. Abstract C113: Multiple modalities of single cell analyses to evaluate the tumor microenvironment in clinical specimens
36. Abstract B019: Effect of oncolytic vaccinia virus-induced IL-7 and IL-12 expression on tumor immune microenvironment in poorly immunogenic murine cancer
37. Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells
38. A call admission control maximizing the number of general calls from non-disaster area considering the priority calls
39. 287 - Gilteritinib Enhances Graft-Versus-Leukemia Effects Against FLT3-ITD+ Leukemia after Mouse Allogeneic HSCT
40. PHLDA1, another PHLDA family protein that inhibits Akt
41. ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma
42. Pit Formation, Patterning and Flattening of Ge Surfaces in O2-Containing Water by Metal-Assisted Chemical Etching
43. Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells
44. Catalytic behavior of metallic particles in anisotropic etching of Ge(100) surfaces in water mediated by dissolved oxygen.
45. IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis
46. Abstract A172: Preclinical antitumor activity of ASP5878, a novel inhibitor of FGFR1, 2, 3 and 4, in FGF19-expressing hepatocellular carcinoma
47. Catalyst-Assisted Electroless Flattening of Ge Surfaces in Dissolved-O2-Containing Water
48. 弾性表面波リニアモータの小型化・薄型化に関する研究
49. 2205 Study on Low-profile Surface Acoustic Wave Motor
50. In vivo functional imaging of biological tissues based on diffuse reflectance spectroscopy with a digital RGB camera
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.